Grifols (GRFS) Completes Acquisition of Talecris Biotherapeutics
Grifols, S.A. (NASDAQ: GRFS) announced that on June 1, 2011, Grifols completed its acquisition of Talecris Biotherapeutics Holdings Corp. In partial consideration for their shares, Talecris shareholders received Grifols non-voting shares that trade in the U.S. as Grifols ADSs. These new Grifols ADSs are listed on the NASDAQ Stock Exchange under the symbol "GRFS."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Proofpoint (PFPT) Acquires Return Path's Email Fraud Protection Unit
- Williams Cos. (WMB) Affirms Receipt of Corvex Board Nominations; Issues Statement
- Momenta Phama (MNTA), Teva (TEVA) Active as '250 Patent on Capoxone Invalid
Create E-mail Alert Related CategoriesCorporate News, Mergers and Acquisitions
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!